Literature DB >> 31894458

Hydrogen sulfide serves as a biomarker in the anterior segment of patients with diabetic retinopathy.

Yuyi Han1, Xiaoqian Zhang2, Zhiyin Zhou3, Mengxi Yu3, Qiuhong Wang3, Jin Yao4,5, Yi Han6.   

Abstract

OBJECTIVE: The present study aims to determine hydrogen sulfide (H2S) concentrations of the aqueous humor from patients with diabetic retinopathy (DR) to compare its levels in the anterior segments, also to investigate its effect on the retinal microvascular endothelial cells under high glucose condition.
METHODS: AH samples were collected from patients with proliferative diabetic retinopathy (n = 11), non-proliferative diabetic retinopathy (n = 12) and diabetic patients without DR as controls (n = 12). There were 5 patients with PDR received intraocular anti-VEGF injection (Lucentis). Cultured RF/6A cells were grouped into control group, mannitol group, high glucose group and NaHS co-administrated high glucose group. Concentrations of H2S were detected by chemical assay. Cell apoptosis was evaluated by flow cytometry.
RESULTS: A significantly higher H2S level was observed in AH samples of PDR patients among other groups. The H2S level of DR group was higher than that of control group. Decreased H2S levels in the AH of post-injected PDR patients were observed compared with their AH samples before the anti-VEGF injection. In cell culture, low concentration of NaHS can reverse high-glucose-induced apoptosis of RF/6A cells.
CONCLUSION: Our study revealed increased H2S levels in the anterior segments of different DR patients. The anti-VEGF injection reduced the H2S level in AH from PDR patients. The study suggested that H2S may serve as a biomarker in the progression of PDR. On the other hand, the H2S donor exerted a protective effect on retinal vascular endothelial cells against high-glucose-induced apoptosis.

Entities:  

Keywords:  Apoptosis; Diabetic retinopathy; Hydrogen sulfide; VEGF

Year:  2020        PMID: 31894458     DOI: 10.1007/s10792-019-01252-z

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  43 in total

1.  IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030.

Authors:  David R Whiting; Leonor Guariguata; Clara Weil; Jonathan Shaw
Journal:  Diabetes Res Clin Pract       Date:  2011-11-12       Impact factor: 5.602

Review 2.  Important causes of visual impairment in the world today.

Authors:  Nathan G Congdon; David S Friedman; Thomas Lietman
Journal:  JAMA       Date:  2003-10-15       Impact factor: 56.272

3.  Frequency and risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy.

Authors:  Akiko Goto; Masaru Inatani; Toshihiro Inoue; Nanako Awai-Kasaoka; Yuji Takihara; Yasuhiro Ito; Mikiko Fukushima; Hidenobu Tanihara
Journal:  J Glaucoma       Date:  2013-09       Impact factor: 2.503

4.  Analysis of the clinical efficacy of intravitreal bevacizumab in the treatment of iris neovascularization caused by proliferative diabetic retinopathy.

Authors:  Yanrong Jiang; Xiaoying Liang; Xiaoxin Li; Yong Tao; Kai Wang
Journal:  Acta Ophthalmol       Date:  2008-09-18       Impact factor: 3.761

5.  Electro-acupuncture protects against hypoxic-ischemic brain-damaged immature rat via hydrogen sulfide as a possible mediator.

Authors:  Ying Liu; Li-Ping Zou; Jun-Bao Du; Virginia Wong
Journal:  Neurosci Lett       Date:  2010-09-09       Impact factor: 3.046

6.  Relationship between apoptotic markers (Bax and Bcl-2) and biochemical markers in type 2 diabetes mellitus.

Authors:  J Hasnan; M I Yusof; T D Damitri; A R Faridah; A S Adenan; T H Norbaini
Journal:  Singapore Med J       Date:  2010-01       Impact factor: 1.858

7.  Comparative localization of cystathionine beta-synthase and cystathionine gamma-lyase in retina: differences between amphibians and mammals.

Authors:  Winnie W Pong; Renata Stouracova; Nina Frank; Jan P Kraus; William D Eldred
Journal:  J Comp Neurol       Date:  2007-11-10       Impact factor: 3.215

8.  Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate.

Authors:  A P Adamis; D T Shima; M J Tolentino; E S Gragoudas; N Ferrara; J Folkman; P A D'Amore; J W Miller
Journal:  Arch Ophthalmol       Date:  1996-01

9.  Calcium entry mediates hyperglycemia-induced apoptosis through Ca(2+)/calmodulin-dependent kinase II in retinal capillary endothelial cells.

Authors:  Jun Li; Peipei Wang; Songping Yu; Zhi Zheng; Xun Xu
Journal:  Mol Vis       Date:  2012-09-20       Impact factor: 2.367

10.  Study of 27 aqueous humor cytokines in patients with type 2 diabetes with or without retinopathy.

Authors:  Ning Dong; Bing Xu; Bingsong Wang; Liqun Chu
Journal:  Mol Vis       Date:  2013-08-04       Impact factor: 2.367

View more
  1 in total

1.  Hydrogen Sulfide Protects Retinal Pigment Epithelial Cells from Oxidative Stress-Induced Apoptosis and Affects Autophagy.

Authors:  Liming Hu; Jia Guo; Li Zhou; Sen Zhu; Chunming Wang; Jiawei Liu; Shanshan Hu; Mulin Yang; Changjun Lin
Journal:  Oxid Med Cell Longev       Date:  2020-12-30       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.